Abstract
In 1945, a United States Public Health Service team in Monrovia, Liberia, began the use of synthetic insecticides for indoor residual spraying (IRS) and as a larvicide, with the goal of controlling malaria in the Liberian capital. In the early 1950s, the project was "scaled up" to reach the surrounding areas, and in 1953, the World Health Organization (WHO) launched an antimalaria program in the upcountry region of Central Province, Liberia. It was initially based solely upon IRS, as it was one of a series of pilot projects whose goal was to determine the feasibility of malaria eradication in tropical Africa. The malaria control project in Monrovia constituted the first large-scale use of synthetic insecticide to combat malaria in tropical Africa, and the WHO pilot project in Central Province was one of a first cluster of projects initiated to explore the efficacy of IRS in a variety of African ecological zones. These projects encountered a spate of difficulties that foreshadowed the general retreat from malaria eradication efforts across tropical Africa by the mid-1960s.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the History of Medicine and Allied Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
